Join the club today. Go to CNBC. com.>> Our newsmaker this hour. Doctor Marty Makary the FDA commissioner marking his first 100 days on the job. It's been a busy few months with many changes at the agency from vaccines to staffing.Good morning doctor. >> Good morning Joe. I don't.>> Know, maybe you've been on a few times. I don't remember, but we all went through that, that period together, obviously. And there's a lot of look back now at, at that period.I was you know it's a hot button issue and sometimes ...

US regulators approved Moderna’s Covid vaccine for children, a positive sign for the company amid Robert F. Kennedy Jr.’s policy positions that have led to restricted access to the shots for kids https://t.co/nIBtdAkS25 ...

The American Academy of Pediatrics is suing HHS Secretary RFK Jr. . saying, quote, "We believe the children deserve better." The lawsuit alleges changes to COVID vaccine recommendations without a scientific reason. And Kennedy's firing of vaccine advisors, replacing them with multiple vaccine skeptics, are illegal and are outside established scientific practice.Joining us now, the president of the American Academy of Pediatrics, Dr. . Susan Cresley. Uh, doctor, thank you so much for joining us.Um, please ex ...

The House Judiciary Committee subpoenaed a former Pfizer executive, demanding he address allegations of deliberately delaying positive news from the company’s Covid vaccine study until after the 2020 election https://t.co/vUf0tiatFl ...

Pfizer (PFE) FY Conference June 09, 2025 08:00 AM ET Speaker0 Great. Good morning, everyone, and welcome to our forty sixth Annual Global Healthcare Conference. My name is Assad Heather. I'm The U. S. Pharma Analyst here at Goldman Sachs. And we are very privileged to have Albert Bula with us to kick up this conference. Albert's the CEO of Pfizer. Albert, thank you for being with us. Speaker1 Great pleasure. Speaker0 Albert, we have about thirty five minutes, so I wanna start with a big picture question for ...

Moderna (MRNA) 2025 Conference June 05, 2025 10:30 AM ET Speaker0 Everyone, thank you. Good morning, and thank you for joining us on our next discussion here at the Jefferies Healthcare Conference. I have the pleasure of having the President of Moderna, Stephen Hoag, up here with us. Obviously, timely. A lot's going on in the world, both from a regulatory administrative standpoint. We had Marty Makary here yesterday. Obviously, a lot going on with your commercial business, the pipeline, all of that. So I lo ...

Company Overview - Moderna is focused on building a diverse portfolio of products utilizing mRNA technology, targeting areas such as infectious diseases, cancer, rare diseases, and autoimmune diseases [3]. Strategic Priorities - The company has outlined three main priorities for the year: 1. To drive sales through approved products, specifically COVID-19 and RSV vaccines [3]. 2. To launch new products to diversify and grow the top line, with up to 10 launches planned over the next few years and several Biologics License Applications (BLAs) already filed [4]. 3. To resize the company from a cost perspective in response to the transition from pandemic-related sales [4].

If you see a stock that pays 6% in dividends, you might assume it's too risky -- but that's not always the case. In some situations, a yield can grow to such heights because investors have been dumping the stock. This can occur due to concerns around a company's business, including poor financial results. It's not a good idea to assume that a high-yielding dividend always means that a reduction in the payout is inevitable. An assumption like that could result in an investor missing out on some great dividen ...

About this content About Ian Lyall Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually. Prior to Proactive, Ian helped lead the business outpu ...

Moderna (MRNA) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Speaker0 Good day, and thank you for standing by. Welcome to the Moderna first quarter '20 '20 '5 conference call. At this time, all participants are in a listen only mode. After the speakers' presentation, there'll be a question and answer session. To ask a question during the session, you need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Pl ...